Fast and Straightforward Method for the Quantification of Pazopanib in Human Plasma Using LC-MS/MS

Background:Pazopanib is an angiogenesis inhibitor approved for renal cell carcinoma and soft-tissue sarcoma. Studies indicate that treatment with pazopanib could be optimized by adapting the dose based on measured pazopanib plasma concentrations.Methods:We describe the validation and clinical applic